Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

MARLINA (BI 1218.89). A phase 3b mulitcenter, multinational, randomized, doubleblind, placebo controlled, paraelle group study to evaluate the glycemic and renal efficacy of once daily administration of Linagliptin 5 mg for 24 weeks in type 2 diabetes patients, with micro or macroalbuminuria (30-3000mg/g creatinine) on top of current standard treatment for diabetic nephropathy (ACE or ARB)

Projekt: Typer af projekterProjekt

Vis graf over relationer
StatusIgangværende
Periode01/01/2013 → …

ID: 44812740